Essential Thrombocythemia: A Case Study - Jerry L. Spivak, Md

Essential Thrombocythemia: A Case Study - Jerry L. Spivak, MD

Cancer Research & Treatment Fund

Essential Thrombocythemia: Pathogenesis and Management

Cancer Research & Treatment Fund

Natural History and Heredity - Jerry L. Spivak, MD

Cancer Research & Treatment Fund

Essential Thrombocythemia

Essential Thrombocythemia: What Patients Should Know (2022) | Top MPN Specialist Dr. Ruben Mesa

The Patient Story

Jerry Spivak, MD - Managing Myelofibrosis in 2023

Cancer Research & Treatment Fund

Treatment goals in Essential Thrombocythemia and Polycythemia vera

Essential Thrombocythemia . Medical Education Podcast

White Coat Hackers

Challenges in the treatment and management of ET and the need to improve therapeutic approaches

VJHemOnc – Video Journal of Hematology & HemOnc

Hematological predictors of thrombotic risk or disease progression in essential thrombocythemia

VJHemOnc – Video Journal of Hematology & HemOnc

Conversation with an MPN Specialist: Focusing on Essential Thrombocythemia

MPN Advocacy & Education International

Unmet needs in the polycythemia vera and essential thrombocythemia

VJHemOnc – Video Journal of Hematology & HemOnc

Novel therapeutics in essential thrombocythemia

VJHemOnc – Video Journal of Hematology & HemOnc

What Are Treatment Options for Essential Thrombocythemia (ET) & Polycythemia Vera (PV)?

Patient Empowerment Network

Dr. Spivak on the Prevalence of Polycythemia Vera

SURPASS ET: P1101 in essential thrombocythemia

VJHemOnc – Video Journal of Hematology & HemOnc

Latest on Current Treatments for Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia

The Patient Story

Results of the phase 4 EXELS study of high-risk patients with essential thrombocythemia

EMJ

Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia: Treatments to Watch For | MPN Update

The Patient Story